Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05430191 · ClinicalTrials.gov registry record
Equitable Implementation of Cascade Screening for Familial Hypercholesterolemia
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 22
- Enrollment target
NCT05430191: Completed study, sponsored by Northwestern University.
NCT05430191 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05430191 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
Design, refine, and pilot the two implementation approaches using behavioral economics and then seek further feedback prior to the proposed clinical trial, consistent with these recommendations. Aim 1. Co-design both implementation strategies using behavioral economics in partnership with the Family Heart Foundation and key partners from diverse backgrounds. Aim 2. Pilot strategies with 20 patients with high cholesterol and/or with familial hypercholesterolemia (FH) to ascertain feasibility, acceptability, appropriateness.
Primary Outcome
We will learn about the perspectives on cascade screening from clinicians and patients with high cholesterol and/or FH (probands) via qualitative interview.
Interventions
- OTHER Cascade Screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2022-07-20 |
| Est. Completion | 2023-06-20 |
What the finished NCT05430191 record still lists
NCT05430191 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Cascade Screening is the first listed.
NCT05430191 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05430191 about?
NCT05430191 is a clinical study titled "Equitable Implementation of Cascade Screening for Familial Hypercholesterolemia". Design, refine, and pilot the two implementation approaches using behavioral economics and then seek further feedback prior to the proposed clinical trial, consistent with these recommendations. Aim 1. Co-design both implementation strategies using behavioral economics in partnership with the Famil...
What is the current status of trial NCT05430191?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2022-07-20. Estimated completion is 2023-06-20.
What interventions are being tested in trial NCT05430191?
The interventions under investigation include: Cascade Screening (OTHER).
Who is sponsoring clinical trial NCT05430191?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI